RGNX update licenses out adeno-associated virus technology to other gene-editing companies. has 20+ partnered programs When NVS acquired AVXS , that triggered a clause in the AVXS-RGNX partnership contract stepped cup cash milestones to RGNX. As a result cash is now more than $420mn.